Na nɔmal tin fɔ fil frayd, shɔk, ɛn nɔr shɔ we yu dɔktɔ tɛl yu ɔr pɔrsin wae yu no se yu gɛt "Stage III" brɔst kansa. Kwɛstyɔn dɛn lɛk ‘Wetin a de du naw?’, ‘Dɛn kin mɛn dis?’, ‘Di tritmɛnt go bi bad?’. sɔntɛm i kin kam na mi maynd. Bɔt nɔ wɔri. Di mɛrɛsin we wi de yuz tide dɔn rili go bifo. So tide, lɛ wi tɔk bɔt dis sik ɛn de sakrifays tritmɛnt fɔ am na wan rili simpul we we yu go ɔndastand.
Wetin rili bi ‘Stage III’?
Fɔ tɔk am simpul wan, na dis stej, di kansa dɔn spre pas di brɛst to di limf no dɛm we de nia, ɔ insay kɔlokyual wɔd dɛm, to di armpit dɛm. Sɔntɛnde, di tumbu kin gro so big dat i kin tay pan di chɛst wɔl ɔ di skin na di bɔdi insɛf.
Na tru se dis kin mek yu fred, bɔt di impɔtant tin na dat, na dis stej, dɛn kin yuz wan kɔmbayn tritmɛnt pas fɔ yuz wan tritmɛnt, ɛn dɛn kin gɛt rili saksesful rizɔlt.
Naw lɛ wi si wetin na dɛn tritmɛnt ya.
Wetin na di men tritmɛnt dɛn?
We yu de trit stej 3 brɔst kansa, yu mɛdikal tim go mek di bɛst tritmɛnt plan we spɛshal fɔ yu kɔndishɔn. Bɔku men tritmɛnt dɛn de we dɛn kin yuz fɔ dis. Mek wi tek wan luk pan dem.
| Di we aw dɛn kin trit am | Fɔ tɔk am simpul wan... |
|---|---|
| Kimotɛrapi | Gi pawaful drɔgs fɔ pwɛl kansa sɛl dɛn. |
| Ɔpreshɔn | Ɔpreshɔn fɔ pul di kansa tɔŋ ɛn di tisu we de rawnd am. |
| Rɛdieshɔn Tɛrapi | Yuz ay-ɛnaji rayt fɔ pwɛl ɛni kansa sɛl we lɛf. |
| Ɔmon Tɛrapi | Fɔ stɔp di akshɔn fɔ di ɔmon dɛm we de ɛp kansa fɔ gro. |
| Tɛrapi we dɛn de tɔk bɔt | Tritmεnt we de tכk bכt wan prכsεs we spεsifi k to kεnsar sεl dεm. |
Okay, naw lɛ wi tɔk bɔt ɛni wan pan dɛn tritmɛnt ya smɔl mɔ.
Kimotɛrapi
Dis na di tritmɛnt we dɛn kin yuz mɔ fɔ stej 3 kansa.
- Bifo dɛn du di ɔpreshɔn: Sɔntɛnde, we big big tumbu dɛn de, dɛn kin gi dɛn kemotɛrapi bifo dɛn du di ɔpreshɔn fɔ mek di tumbu smɔl . Dis kin mek di ɔpreshɔn izi ɛn i kin wok fayn.
- Afta dɛn dɔn du di ɔpreshɔn: Kimotɛrapi kin ɛp fɔ pwɛl ɛni kansa sɛl we kin de na di bɔdi afta dɛn dɔn du di ɔpreshɔn, bɔt we pɔsin nɔ kin si wit in yay.
- As di men tritmɛnt: Sɔntɛnde, if ɔpreshɔn nɔ pɔsibul, dɛn kin yuz kemotɛrapi as di men tritmɛnt.
Dɛn kin tek dis tritmɛnt lɛk pil ɔ likwid, bɔt dɛn kin gi am mɔ tru wan vein (intravenous ɔ IV). Dɛn go gi yu brek bitwin saykl dɛn fɔ mek yu bɔdi ebul fɔ ajɔst.
Ɔpreshɔn
Bɔku tɛm, dɛn kin du ɔpreshɔn afta we di kemotɛrapi dɔn mek di tumbu smɔl. Tu men kayn dɛn de:
- Lumpectomy: Dis min se dɛn kin pul di kansa tɔŋ ɛn smɔl smɔl wɛlbɔdi tisu we de rawnd am, ɛn lɛf di bɔdi intakt.
- Mastectomy: Dis min se dɛn kin pul di wan ol bɔdi.
Ilɛk us ɔpreshɔn yu du, dɛn go pul di limf no dɛm na di armpit usay di kansa dɔn skata . Afta dɛn dɔn du ɔpreshɔn, mɔ afta dɛn dɔn pul yu mama, yu kin gɛt di opshɔn bak fɔ mek dɛn du ɔpreshɔn fɔ mek yu bɔdi fayn bak if yu want. Tɔk to yu dɔktɔ bɔt dis.
Rɛdieshɔn Tɛrapi
Afta dɛn dɔn du di ɔpreshɔn, dɛn kin yuz dis tritmɛnt fɔ pwɛl ɛni smɔl smɔl kansa sɛl we kin lɛf na di say we dɛn du di ɔpreshɔn. I tan lɛk se dɛn de skrab ɛn rins fayn fayn wan. Dis kin rili ridyus di risk fɔ mek kansa kam bak na di sem eria.
Ɔmon Tɛrapi
Dis tritmɛnt nɔ fayn fɔ ɔlman. I impɔtant fɔ pipul dɛn nɔmɔ we gɛt "ɔmon riseptɔ-pɔzitiv" kansa.
Wetin dat min?
Fɔ tɔk am simpul wan, ɔmon dɛn lɛk ɛstrojen na wi bɔdi kin ɛp dɛn kansa sɛl dɛn de fɔ gro. So dis tritmɛnt kin stɔp dɛn ɔmon dɛn de fɔ mek dɛn nɔ rich di kansa sɛl dɛn ɔ i kin mek dɛn ɔmon dɛn de nɔ wok.
- Di drɔg `Tamoxifen` na in dɛn kin yuz fɔ dis.
- dεn kin gi uman dεm we dεn kכl aromatase inhibito dεm lεk anastrozole (Arimidex) εn letrozole (Femara).
Wan nyu we fɔ trit: Targeted Therapy
Dis na wan pan di tin dɛn we dɔn go bifo pan tritmɛnt fɔ kansa. Dɛn tritmɛnt ya nɔ tan lɛk kemotɛrapi, dɛn kin tɔch wan patikyula wikɛd ɔ target na di kansa sɛl dɛn.
- HER2-Positiv Kεnsar: sכm brεst kεnsar dεm gεt tu mכch wan protin we dεn kכl `HER2`. Dis kin mek di kansa gro kwik kwik wan. Dɛn kin gi dɛn pipul ya drɔgs lɛk `trastuzumab (Herceptin)` ɛn `pertuzumab (Perjeta).` Dɛn wan ya de wok bay we dɛn de stɔp di akshɔn we di `HER2` protin de du ɛn kɔntrol di kansa.
- BRCA jin mכtεshכn: sכm kεnsar dεm de kכz fכ mכtεshכn na di `BRCA` jin. Fɔ dɛn pipul ya, wan klas ɔf drɔgs we dɛn kɔl `PARP inhibitors` (e.g. `olaparib (Lynparza)`) kin rili wok.
- apat frכm dat, כda tεrapi dεm de we dεn tכk bכt lεk `CDK 4/6 inhibito dεm` εn `PIK3CA inhibito dεm`. Dipen pan di kayn kansa we yu gɛt, di dɔktɔ dɛn go disayd uswan pan dɛn tritmɛnt ya we go fayn fɔ yu.
Tink bak bɔt klinik trial dɛn.
Dis na stɔdi dɛm we stil de na di risach stej, we de tɛst di kɔt-ɛj tritmɛnt dɛm. Sɔm pasɛnt dɛn we gɛt stej 3 kansa kin gɛt di chans fɔ tek pat pan `Klinik Trayal` lɛk dis. Tru dis, yu kin gɛt di laytst tritmɛnt dɛm na di wɔl. Nɔ fɔgɛt fɔ aks yu dɔktɔ fɔ no mɔ bɔt dis.
Mɛsej we dɛn kin kɛr go na os
- Pan ɔl we stej 3 brɔst kansa na siriɔs sik, dɛn kin trit am ɛn dɛn kin ebul fɔ kɔntrol am . Ɛspɛshali we dɛn yuz bɔku tritmɛnt dɛn togɛda, dɛn kin gɛt rili sakrifays.
- Di tritmɛnt plan we yu de gɛt na fɔ yu, bay di kayn we aw yu gɛt kansa (e.g., ɔmon-sɛnsitiv, HER2-positiv).
- Duya nɔ fred fɔ aks yu dɔktɔ ɛni kwɛstyɔn ɔ wɔri bɔt di tritmɛnt dɛn ɔ di sayd ɛfɛkt dɛn we dɛn kin gɛt. Dɛn dɔn mekɔp dɛn maynd fɔ ɛp yu.
- Fɔ mek yu gɛt strɔng maynd ɛn fɔ gɛt di sɔpɔt fɔ yu fambul ɛn padi dɛn rili impɔtant we yu de travul. Nɔ sɔfa yu wan.
- Tɛnki fɔ di mɔdan we dɛn lɛk di tritmɛnt dɛn we dɛn kin tɔk to, bɔku bɛtɛ op de fɔ trit bɔdi kansa tide pas aw i bin de bifo.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt